Accenture Reports Very Strong Second-Quarter Results and Raises Business Outlook for Fiscal 2021
NEW YORK--(BUSINESS WIRE)--Accenture (NYSE: ACN) reported financial results for the second quarter of fiscal 2021, ended Feb. 28, 2021, with...
NEW YORK--(BUSINESS WIRE)--Accenture (NYSE: ACN) reported financial results for the second quarter of fiscal 2021, ended Feb. 28, 2021, with...
- Year-end 2020 cash, cash equivalents and marketable securities of $326.5 million, with projected runway into the second half of...
Marseille, March 18, 2021 (GLOBE NEWSWIRE) --Lacutamab received PRIME designation from the European Medicines Agency in Sezary Syndrome; clinical development...
Cash position of €62 million at year-end provides runway until the end of H2 2022Enrolment of SENS-401 Phase 2 SSNHL...
Outlines 2021 product pipeline milestones for COVID-19, influenza A and norovirus antiviral programsEnds 2020 with cash exceeding $33 million and...
Net earnings attributable to shareholders of the Corporation ("net earnings") were $607.5 million or $0.55 per diluted share for the...
ImmunoPrecise and Genmab enter into a technology partnership targeting infectious diseaseImmunoPrecise and Litevax advance SARS-CoV-2 vaccine candidate for further pre-clinical...
MCLEAN, Va.--(BUSINESS WIRE)--Mar 17, 2021--KLDiscovery Inc. (“KLDiscovery” or the “Company”), a leading global provider of electronic discovery, information governance and...
Plug Electricity GenDrive Gas Cell with GenFuel hydrogen.Resource: Plug AbilityShares of Plug Ability dropped on Wednesday immediately after the business...
Three woman financial players provide finest procedures to the desk in a program that aims to foster elevation, endurance and...
CHARLOTTESVILLE, Va., March 17, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical...
Clinical data and program update planned for lead program zenocutuzumab (“Zeno”) in 2Q 2021Clinical update planned for MCLA-145 in 2H...
– FOTIVDA® (tivozanib) Approved for Adult Patients with Relapsed or Refractory Advanced Renal Cell Carcinoma Following Two or More Prior...
- First patient for Phase 1/2 SUNRISE trial expected to be enrolled in early 2021-Translational preclinical data for sAAVy platform...
MINNEAPOLIS, March 15, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI) – Predictive Oncology (Nasdaq: POAI), a knowledge-driven company focused...
TORONTO, ON / ACCESSWIRE / March 15, 2021 / 01 Communique Laboratory Inc. (the "Company") (TSX-V:ONE)(OTCQB:OONEF) one of the first-to-market,...
BOSTON--(Business WIRE)--Mar 15, 2021--PureTech Overall health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Organization") designs to publish its once-a-year...
BloombergTrader Arrested as WallStreetBets Phenomenon Finds Echo in Japan(Bloomberg) -- A retail investor purchases shares in a modest enterprise, touts...